Literature DB >> 12230217

High rate of vaginal infections caused by non-C. albicans Candida species among asymptomatic women.

M Dan1, F Poch, D Levin.   

Abstract

A prospective observational study of patients attending a gynecological clinic and those referred to a clinic for genitourinary infections was undertaken with the purpose of evaluating the relative prevalence of non-C. albicans Candida species among Candida isolates from the vagina in different clinical settings in an area with high occurrence of vulvovaginal candidiasis. The rate of non-C. albicans Candida species was 44.5% among asymptomatic women, 19.4% among those with sporadic vaginitis and 21% among patients with chronic vaginal symptoms (p < 0.001 for asymptomatic vs. pooled symptomatic women). No increase in the rate of non-C. albicans Candida was observed during a period of 4 years (1995-1998) despite a 1.57-fold increase in the sales of azole antifungal agents. Unlike some previous reports we could not document an association of non-C. albicans Candida species with chronic vaginal symptoms or increased use of azole antifungal agents. The significantly higher rate of these yeasts in asymptomatic women is in accord with the known tendency of non-C. albicans Candida species to cause mild symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230217     DOI: 10.1080/mmy.40.4.383.386

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  8 in total

1.  Simple method for screening Candida species isolates for the presence of secreted proteinases: a tool for the prediction of successful inhibitory treatment.

Authors:  Jií Dostál; Petr Hamal; Libuse Pavlícková; Milan Soucek; Tomás Ruml; Iva Pichová; Olga Hrusková-Heidingsfeldová
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology.

Authors:  Hubertine M E Willems; David J Lowes; Katherine S Barker; Glen E Palmer; Brian M Peters
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

3.  The Evaluation of the virulence factors of clinical Candida isolates and the anti-biofilm activity of Elettaria cardamomum against multi-drug resistant Candida albicans.

Authors:  P Vijayalakshmi; S Thenmozhi; P Rajeswari
Journal:  Curr Med Mycol       Date:  2016-06

4.  Identification of Candida species isolated from vulvovaginitis using matrix assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Majid Alizadeh; Anna Kolecka; Teun Boekhout; Hossein Zarrinfar; Mohamad A Ghanbari Nahzag; Parisa Badiee; Ali Rezaei-Matehkolaei; Abdolmajid Fata; Somayeh Dolatabadi; Mohammad J Najafzadeh
Journal:  Curr Med Mycol       Date:  2017-12

Review 5.  Vulvovaginal Candidiasis: A Current Understanding and Burning Questions.

Authors:  Hubertine M E Willems; Salman S Ahmed; Junyan Liu; Zhenbo Xu; Brian M Peters
Journal:  J Fungi (Basel)       Date:  2020-02-25

6.  Prevalence of Candida spp. and age-related disparities amongst women presenting with vaginitis at the Obstetrics and Gynaecology (O&G) Clinic in a Tertiary hospital in Port Harcourt, Nigeria.

Authors:  Chiaka Mbakwem-Aniebo; Anwuli Uche Osadebe; Eunice Athanasonny; Iheanyi Omezurike Okonko
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

Review 7.  It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset.

Authors:  Andrea Ardizzoni; Robert T Wheeler; Eva Pericolini
Journal:  Front Microbiol       Date:  2021-06-07       Impact factor: 6.064

8.  Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.

Authors:  Sayanika Devi Waikhom; Innocent Afeke; Grace Sefakor Kwawu; Hintermann Kobina Mbroh; George Yiadom Osei; Bengyella Louis; John Gameli Deku; Emmanuel Senyo Kasu; Prosper Mensah; Charles Yao Agede; Cornelius Dodoo; Emmanuel Akomanin Asiamah; John Tampuori; John Korbuvi; Japheth Awuletey Opintan
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-06       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.